Innate Therapeutics receives funding to conduct Phase 2A clinical ... - News-Medical.Net

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service73 times read : Adjust font size: Decrease font Enlarge font
image

Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds ...

Read this article...



Post your comment comment Comments (0 posted)

copyright